Among patients with rheumatoid arthritis, JAK inhibitors were slightly more effective for reducing pain at 3 and 12 months when compared with TNF inhibitors.

An international quality improvement initiative focused on supporting rheumatoid arthritis (RA) patients to reach their full ...